Aprogen Pharmaceuticals Inc Net Asset Momentum
Aprogen Pharmaceuticals Inc net asset momentum. Aprogen Pharmaceuticals Inc (003060) recorded a net asset momentum of 2.7% as of December 2024, with net assets of ₩378.69 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Aprogen Pharmaceuticals Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Aprogen Pharmaceuticals Inc (2009–2024)
Net asset momentum of Aprogen Pharmaceuticals Inc from 2009 to 2024. This chart tracks Aprogen Pharmaceuticals Inc's year-over-year net asset growth across 17 annual reporting periods from 2009 to 2024. The most recent momentum reading is +2.7%, with net assets of ₩378.69 Billion KRW as of December 2024. See shareholders equity of Aprogen Pharmaceuticals Inc for net asset value and shareholders' equity analysis.
Aprogen Pharmaceuticals Inc Net Asset Momentum by Year (2009–2024)
Aprogen Pharmaceuticals Inc net asset momentum by year from 2009 to 2024. The table below shows the complete annual net asset history for Aprogen Pharmaceuticals Inc from 2009 to 2024, covering 17 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 003060 market cap overview.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | ₩378.69 Billion | ₩590.98 Billion | ₩212.29 Billion | ▲ +2.7% |
| 2023 | ₩368.69 Billion | ₩589.40 Billion | ₩220.71 Billion | ▼ -27.8% |
| 2022 | ₩510.41 Billion | ₩684.14 Billion | ₩173.73 Billion | ▼ -14.5% |
| 2021 | ₩597.18 Billion | ₩614.62 Billion | ₩17.44 Billion | ▼ -0.2% |
| 2020 | ₩598.36 Billion | ₩615.31 Billion | ₩16.95 Billion | ▲ +72.1% |
| 2019 | ₩347.64 Billion | ₩365.28 Billion | ₩17.65 Billion | ▲ +131.0% |
| 2018 | ₩150.51 Billion | ₩217.06 Billion | ₩66.55 Billion | ▲ +93.3% |
| 2017 | ₩77.86 Billion | ₩158.27 Billion | ₩80.41 Billion | ▼ -0.3% |
| 2016 | ₩78.12 Billion | ₩128.69 Billion | ₩50.57 Billion | ▲ +15.3% |
| 2015 | ₩67.75 Billion | ₩85.22 Billion | ₩17.48 Billion | ▲ +9.1% |
| 2014 | ₩62.11 Billion | ₩84.83 Billion | ₩22.71 Billion | ▲ +9.8% |
| 2013 | ₩56.55 Billion | ₩78.26 Billion | ₩21.71 Billion | ▼ -17.5% |
| 2012 | ₩68.51 Billion | ₩93.08 Billion | ₩24.58 Billion | ▼ -6.8% |
| 2011 | ₩73.49 Billion | ₩116.33 Billion | ₩42.85 Billion | ▲ +71.7% |
| 2010 | ₩42.81 Billion | ₩78.70 Billion | ₩35.89 Billion | ▲ +3.5% |
| 2010 | ₩41.38 Billion | ₩67.64 Billion | ₩26.26 Billion | ▲ +64.3% |
| 2009 | ₩25.18 Billion | ₩59.07 Billion | ₩33.89 Billion | — |